Evidence map›Paper›PMID 35395871›Full record

ArticleScientific reports2022

The burden and trend of gastric cancer and possible risk factors in five Asian countries from 1990 to 2019.

Fei-Long Ning, Jun Lyu, Jun-Peng Pei, Wan-Jie Gu, Nan-Nan Zhang, Shi-Yi Cao, Yong-Ji Zeng, Masanobu Abe, Kazuhiro Nishiyama, Chun-Dong Zhang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 1 synthesis or guideline pooled it, 46 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. One cancer, two stories: divergent estimates of gastric cancer burden in Korea.Archives of public health = Archives belges de sante publique · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 10 institutions in 3 countries.

Fei-Long Ning *Department of General Surgery, The Affiliated Xuzhou Hospital of Nanjing University of Chinese Medicine, Xuzhou Hospital of Traditional Chinese Medicine, Xuzhou, 221003, China.
Jun Lyu *Department of Clinical Research, The First Affiliated Hospital of Jinan University, Guangzhou, 510630, China.
Jun-Peng Pei *Department of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, No.4 Chongshan East Road, Huanggu, Shenyang, 110032, China.
Wan-Jie GuEvidence-Based Medicine Group, Department of Anesthesiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, 210008, China.
Nan-Nan ZhangState Key Laboratory of Cancer Biology and National Clinical Research Center for Digestive Diseases, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an, 710032, China.
Shi-Yi CaoSchool of Public Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.
Yong-Ji ZengSection of Gastroenterology, Department of Medicine, Baylor College of Medicine, Houston, TX, 77030, USA.
Masanobu AbeDivision for Health Service Promotion, The University of Tokyo, Tokyo, 113-8655, Japan.
Kazuhiro NishiyamaDepartment of Gastrointestinal Surgery, Graduate School of Medicine, Kyoto University, Kyoto, 606-8507, Japan.
Chun-Dong ZhangDepartment of Gastrointestinal Surgery, The Fourth Affiliated Hospital of China Medical University, No.4 Chongshan East Road, Huanggu, Shenyang, 110032, China. zhangchundong2007@126.com.
Baylor College of Medicine · USChina Medical University · CNFirst Affiliated Hospital of Jinan University · CNFourth Affiliated Hospital of China Medical University · CNHuazhong University of Science and Technology · CNKyoto University · JPNanjing Drum Tower Hospital · CNNanjing University of Chinese Medicine · CNNational Clinical Research Center for Digestive Diseases · CNThe University of Tokyo · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The burdens and trends of gastric cancer are poorly understood, especially in high-prevalence countries. Based on the Global Burden of Disease Study 2019, we analyzed the incidence, death, and possible risk factors of gastric cancer in five Asian countries, in relation to year, age, sex, and sociodemographic index. The annual percentage change was calculated to estimate the trends in age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR). The highest ASIR per 100,000 person-years in 2019 was in Mongolia [44 (95% uncertainty interval (UI), 34 to 55)], while the lowest was in the Democratic People's Republic of Korea (DPRK) [23 (95% UI, 19 to 29)]. The highest ASDR per 100,000 person-years was in Mongolia [46 (95% UI, 37 to 57)], while the lowest was in Japan [14 (95% UI, 12 to 15)]. Despite the increase in the absolute number of cases and deaths from 1990 to 2019, the ASIRs and ASDRs in all five countries decreased with time and improved sociodemographic index but increased with age. Smoking and a high-sodium diet were two possible risk factors for gastric cancer. In 2019, the proportion of age-standardized disability-adjusted life-years attributable to smoking was highest in Japan [23% (95% UI, 19 to 28%)], and the proportions attributable to a high-sodium diet were highest in China [8.8% (95% UI, 0.21 to 33%)], DPRK, and the Republic of Korea. There are substantial variations in the incidence and death of gastric cancer in the five studied Asian countries. This study may be crucial in helping policymakers to make better decisions and allocate appropriate resources.

Indexed as

Stomach NeoplasmsGlobal Burden of DiseaseGlobal HealthHumansIncidenceQuality-Adjusted Life YearsRisk FactorsSodiumSodium

Identifiers

PMID35395871
PMCPMC8993926
OpenAlexW4223653131

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.